Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 13 of 312 for:    ASPIRIN AND clopidogrel AND dual

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation (OPT-PEACE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03198741
Recruitment Status : Recruiting
First Posted : June 26, 2017
Last Update Posted : June 18, 2019
Sponsor:
Collaborators:
Changhai Hospital
ANKON medical technologies (Shanghai)Co.,LTD
Information provided by (Responsible Party):
Han Yaling, Shenyang Northern Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 30, 2020
Estimated Study Completion Date : July 30, 2020